
Journey Biosciences is a digital health leader focused on transforming diabetes care through preventive technologies and AI-powered insights. Their flagship product, NaviDKD®, is a blood test that predicts the risk of diabetes-related kidney disease (DKD) years before symptoms appear. It works in conjunction with Compass™, an AI-driven digital platform that translates lab data into risk reports and personalized treatment options. This combination aims to enable early intervention, improve patient outcomes, and reduce healthcare costs by allowing patients and providers to take proactive steps to protect kidney health.

Journey Biosciences is a digital health leader focused on transforming diabetes care through preventive technologies and AI-powered insights. Their flagship product, NaviDKD®, is a blood test that predicts the risk of diabetes-related kidney disease (DKD) years before symptoms appear. It works in conjunction with Compass™, an AI-driven digital platform that translates lab data into risk reports and personalized treatment options. This combination aims to enable early intervention, improve patient outcomes, and reduce healthcare costs by allowing patients and providers to take proactive steps to protect kidney health.